To fully advance Nanjing’s strategy of strengthening the city through industrial development and give full play to venture capital’s role in investing in early-stage projects, small enterprises, and hard-core technology, Nanjing has established a RMB 4 billion Sci-Tech Innovation Primary Investing. The Primary Investing is now openly selecting qualified management institutions for planned sub-funds from society. Relevant details are announced as follows:

In accordance with relevant regulations including the Implementation Measures for the Management of Jiangsu Provincial Government Investment Funds and the Partnership Agreement of Nanjing Yuhuadingxin Xingchen Venture Capital Partnership (Limited Partnership), Shenzhen Dingxin Capital Management Co., Ltd., the manager of Nanjing Yuhuadingxin Xingchen Venture Capital Partnership (Limited Partnership) (hereinafter referred to as the "Fund"), is selecting a fund custodian bank. The selection plan for the fund custodian bank is hereby announced as follows:

In accordance with relevant regulations, Nanjing Enran Chengfeng Venture Capital Partnership (Limited Partnership) (the "Fund") is selecting a fund custodian bank. The selection plan for the fund custodian bank is hereby announced as follows:

On March 24, 2026, Nanjing Zijing Science & Technology Innovation Primary Investing Partnership (Limited Partnership) (hereinafter referred to as the "S&T Innovation Primary Investing") held the 5th meeting of its Sub-Fund Investment Decision Committee, which reviewed and approved the sub-funds proposed for equity participation by the S&T Innovation Primary Investing. Details are as follows:

On January 29, 2026, the Jiangsu Nanjing Advanced Manufacturing Industry Special Fund (Limited Partnership) (hereinafter referred to as the "Industry Special Fund") held its fourth sub-fund investment decision committee meeting. The meeting reviewed and approved the sub-funds in which the Industry Special Fund intends to participate, as detailed below:

On January 8, 2026, Jiangsu Nanjing Advanced Manufacturing Industry Special Master Fund (Limited Partnership) (hereinafter referred to as the "Industry Special Master Fund") held the third meeting of its Sub-Fund Investment Decision-Making Committee, which reviewed and approved the proposed participating sub-funds of the Industry Special Master Fund, details are as follows:

Recently, Wuxi Lipu Semiconductor Co., Ltd. (hereinafter referred to as "Lipu Semiconductor"), an enterprise invested by Nanjing Delian Xingyao Investment Center (Limited Partnership) (hereinafter referred to as "Delian Xingyao Fund") — a sub-fund cooperating with Nanjing Innovation Investment Group, has closed a Pre-B+ round financing worth hundreds of millions of yuan. This financing is jointly invested by Yangzhou Guojin and Yangzhou Longtou Capital. The funds will be mainly used for the construction of a professional automotive-grade SiC module packaging and testing base in Yangzhou and global market promotion, so as to further enhance the company’s production capacity and competitiveness in the field of high-voltage and high-power power semiconductors.

Recently, Jiangsu Silicon Mountain Technology Co., Ltd. (hereinafter referred to as "Silicon Mountain Technology"), an enterprise directly invested in by Nanjing Venture Capital Group, has completed industrial and commercial registration, marking the official settlement of its headquarters in Jiangxinzhou Sub-district, Jianye District, Nanjing.

On March 25, Chengdu Hongming Electronics Co., Ltd. ("Hongming Electronics"), invested by Jucheng Qiushi Equity Investment Partnership (Limited Partnership), a cooperative sub-fund of Nanjing Innovation Investment Group, was officially listed on the ChiNext board of the Shenzhen Stock Exchange with the stock code 301682.SZ.

Recently, Nanjing RuiChu Pharmaceutical Co., Ltd. (“RuiChu Pharma”), a direct-investment portfolio company of Nanjing Innovation Investment Group, announced a major R&D breakthrough: RC017, an innovative in-house drug targeting aging mechanisms for eye diseases, has officially received the Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA).

On March 25, 2026, SeeYA Technology Co., Ltd. (“SeeYA Technology”), an enterprise invested by Nanjing Yuanjun Equity Investment Partnership (L.P.) (“Nanjing Yuanjun Fund”), a sub-fund cooperated with Nanjing Venture Capital Group, was officially listed on the Shanghai Stock Exchange STAR Market under the stock code 688781.SH, becoming the first listed company in China focusing on silicon-based OLED.

Recently, Beijing Boson Quantum Technology Co., Ltd. (“Boson Quantum”), an enterprise invested by Shenzhen Qifu Angel Private Equity Venture Capital Fund Partnership (L.P.) (“Qifu Angel Fund”), a co‑operated sub‑fund of Nanjing Innovation Investment Group (“NJICG”), was featured in the headline report of CCTV News Network. Its technological achievements in quantum computing were highlighted as a representative innovation in future industries.